| FILAMENT-HEALTH-CORP |
FILAMENT-HEALTH-CORP |
85%
|
ical trials related to Psyence’s proposed products or the therapeutic areas in which Psyence’s proposed products will compete could have a material adverse effect on Psyence’s business, prospects, fi… |
| CGC |
Canopy Growth Corporation |
72%
|
Reciprocal relationship from CGC graph: Reciprocal relationship from PBM graph: nabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr… |
| CGC |
Canopy Growth Corporation |
72%
|
nabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co-founded Indigo Properties, a business focused on commercial and … |
| AQUACAP-LIMITED |
AQUACAP-LIMITED |
62%
|
nabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co-founded Indigo Properties, a business focused on commercial and … |
| AUSTRALIA-FOR-PSYENCE-AUSTRALIA-PTY-LTD |
AUSTRALIA-FOR-PSYENCE-AUSTRALIA-PTY-LTD |
62%
|
license the use, development and commercialization rights to our product candidates or technology from third parties or, in certain cases, we fail to meet certain development deadlines, we could lose… |
| CO-LLC |
CO-LLC |
62%
|
hares pursuant to the Debt for Equity Exchange Agreements resulted in a fair value gain of $ 377,897 which was recorded in the consolidated statements of income/(loss) and comprehensive income/(loss)… |
| COMPANY-NEWCOURT-ACQUISITION-CORP |
COMPANY-NEWCOURT-ACQUISITION-CORP |
62%
|
the Common Shares may be volatile and could decline significantly. The stock markets, including Nasdaq, on which the Company lists its securities, have from time to time experienced significant price… |
| MINDHEALTH-BIOMED-CORP |
MINDHEALTH-BIOMED-CORP |
62%
|
Corden-Lloyd has also served as Chief Financial Officer of PGI from May 21, 2020 until his resignation in January 2024. Mr. Corden-Lloyd is a Chartered Accountant and Certified Project Manager. He ha… |
| NASDAQ-STOCK-MARKET-LLC |
NASDAQ-STOCK-MARKET-LLC |
62%
|
manufacturing or selling our product candidates. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than us or the third parties from whom we licen… |
| NEWCOURT-SPAC-SPONSOR-LLC |
NEWCOURT-SPAC-SPONSOR-LLC |
62%
|
the Common Shares may be volatile and could decline significantly. The stock markets, including Nasdaq, on which the Company lists its securities, have from time to time experienced significant price… |
| NEW-YORK-MELLON-CORPORATION |
NEW-YORK-MELLON-CORPORATION |
62%
|
Corden-Lloyd has also served as Chief Financial Officer of PGI from May 21, 2020 until his resignation in January 2024. Mr. Corden-Lloyd is a Chartered Accountant and Certified Project Manager. He ha… |
| OUI-THERAPEUTICS-INC |
OUI-THERAPEUTICS-INC |
62%
|
nabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co-founded Indigo Properties, a business focused on commercial and … |
| PASSIVE-FOREIGN-INVESTMENT-COMPANY |
PASSIVE-FOREIGN-INVESTMENT-COMPANY |
62%
|
the Common Shares may be volatile and could decline significantly. The stock markets, including Nasdaq, on which the Company lists its securities, have from time to time experienced significant price… |
| PRICEWATERHOUSECOOPERS-INTERNATIONAL-LIMITED |
PRICEWATERHOUSECOOPERS-INTERNATIONAL-LIMITED |
62%
|
Corden-Lloyd has also served as Chief Financial Officer of PGI from May 21, 2020 until his resignation in January 2024. Mr. Corden-Lloyd is a Chartered Accountant and Certified Project Manager. He ha… |
| PSILOCYBIN-ENHANCED-GROUP |
PSILOCYBIN-ENHANCED-GROUP |
62%
|
ase of Psyence’s activities, specifically phase II clinical trials which, at present, consists of the Phase IIb Study. The license is granted on an exclusive basis solely within the territory of the … |
| PSYENCE-GROUP |
PSYENCE-GROUP |
62%
|
and in performing the fair value calculations in order to determine (a) the values attributed to each component of a transaction at the time of their issuance; (b) the fair value measurements for cer… |
| PSYENCE-GROUP-INC |
PSYENCE-GROUP-INC |
62%
|
s to United States Dollars. The Board of Directors believe that US Dollar financial reporting provides more relevant presentation of the Company’s financial position, funding and treasury functions, … |
| PSYENCE-LABS-LTD |
PSYENCE-LABS-LTD |
62%
|
hares pursuant to the Debt for Equity Exchange Agreements resulted in a fair value gain of $ 377,897 which was recorded in the consolidated statements of income/(loss) and comprehensive income/(loss)… |
| PTY-LIMITED |
PTY-LIMITED |
62%
|
nabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co-founded Indigo Properties, a business focused on commercial and … |
| SECOND-PSILOCYBIN-GROUP |
SECOND-PSILOCYBIN-GROUP |
62%
|
ase of Psyence’s activities, specifically phase II clinical trials which, at present, consists of the Phase IIb Study. The license is granted on an exclusive basis solely within the territory of the … |
| SOUTHERN-STAR-RESEARCH-PTY-LTD |
SOUTHERN-STAR-RESEARCH-PTY-LTD |
62%
|
ical trials related to Psyence’s proposed products or the therapeutic areas in which Psyence’s proposed products will compete could have a material adverse effect on Psyence’s business, prospects, fi… |
| WHITE-LION-CAPITAL-LLC |
WHITE-LION-CAPITAL-LLC |
62%
|
hares pursuant to the Debt for Equity Exchange Agreements resulted in a fair value gain of $ 377,897 which was recorded in the consolidated statements of income/(loss) and comprehensive income/(loss)… |
